HWKN trades 24.8% below Wall Street's consensus target of $170.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes HWKN achieves its forward estimates and maintains a stable P/E multiple of 34.6x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Hawkins, Inc. (HWKN) has a Wall Street consensus price target of $170.00, based on estimates from 1 covering analysts. With the stock currently trading at $136.26, this represents a potential upside of +24.8%. The company has a market capitalization of $2.84B.
Analyst price targets range from a low of $170.00 to a high of $170.00, representing a 0% spread in expectations. The median target of $170.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, HWKN trades at a trailing P/E of 34.8x and forward P/E of 34.6x. The forward PEG ratio of 2.28 reflects a premium valuation. Analysts expect EPS to grow +0.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $80.72, with bear and bull scenarios of $50.86 and $106.36 respectively. Model confidence stands at 47/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
IOSPInnospec Inc. | $2.0B | $81.66 | $115.00 | +40.8% | Hold | 17.1x | 9 |
KWRQuaker Chemical Corporation | $2.7B | $153.41 | $176.75 | +15.2% | Buy | 21.9x | 14 |
BCPCBalchem Corporation | $5.4B | $168.11 | $175.50 | +4.4% | Buy | 32.1x | 10 |
CBTCabot Corporation | $4.6B | $87.41 | $89.75 | +2.7% | Buy | 13.8x | 15 |
TROXTronox Holdings plc | $976M | $6.12 | $8.33 | +36.1% | Buy | — | 17 |
CCThe Chemours Company | $2.8B | $18.85 | $25.75 | +36.6% | Hold | 13.6x | 20 |
OLNOlin Corporation | $2.4B | $20.74 | $28.30 | +36.5% | Hold | 292.9x | 35 |
ASIXAdvanSix Inc. | $565M | $20.97 | $22.00 | +4.9% | Buy | 14.6x | 6 |
NTICNorthern Technologies International Corporation | $84M | $8.80 | — | — | — | — | — |
LINLinde plc | $249.4B | $538.23 | $562.14 | +4.4% | Buy | 30.1x | 28 |
Quick answers to the most common questions about buying HWKN stock.
The consensus Wall Street price target for HWKN is $170, representing 24.8% upside from the current price of $136.26. With 1 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
HWKN has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $170 implies 24.8% upside from current levels.
HWKN trades at a forward P/E of 34.6321x, representing a moderate valuation. With analysts targeting $170 (24.8% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $170 for HWKN, while the most conservative target is $170. The consensus of $170 represents the median expectation. Our quantitative valuation model projects a bull case target of $106 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
HWKN is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HWKN stock forecast based on 1 Wall Street analysts shows a consensus price target of $170, with estimates ranging from $170 (bear case) to $170 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $81, with bear/bull scenarios of $51/$106.
Our quantitative valuation model calculates HWKN's fair value at $81 (base case), with a bear case of $51 and bull case of $106. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 47/100.
HWKN trades at a forward P/E ratio of 34.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 34.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on HWKN, with a "Buy" consensus rating and $170 price target (24.8% upside). 1 of 1 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HWKN analyst price targets range from $170 to $170, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $170 consensus represents the middle ground. Our model's $51-$106 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.